RPg Family Wealth Advisory LLC Grows Stock Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)

RPg Family Wealth Advisory LLC lifted its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 1.1% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 17,904 shares of the exchange traded fund’s stock after buying an additional 200 shares during the period. RPg Family Wealth Advisory LLC’s holdings in SPDR S&P Biotech ETF were worth $1,612,000 as of its most recent SEC filing.

Several other large investors have also recently modified their holdings of XBI. Golden State Wealth Management LLC purchased a new position in shares of SPDR S&P Biotech ETF in the fourth quarter worth about $29,000. Kohmann Bosshard Financial Services LLC purchased a new position in SPDR S&P Biotech ETF during the 4th quarter valued at about $29,000. Avior Wealth Management LLC increased its holdings in SPDR S&P Biotech ETF by 393.6% during the 4th quarter. Avior Wealth Management LLC now owns 385 shares of the exchange traded fund’s stock valued at $35,000 after purchasing an additional 307 shares during the period. Tidemark LLC increased its holdings in SPDR S&P Biotech ETF by 101.5% during the 3rd quarter. Tidemark LLC now owns 395 shares of the exchange traded fund’s stock valued at $39,000 after purchasing an additional 199 shares during the period. Finally, Bank of Jackson Hole Trust purchased a new position in SPDR S&P Biotech ETF during the 4th quarter valued at about $43,000.

SPDR S&P Biotech ETF Price Performance

Shares of NYSEARCA:XBI opened at $85.97 on Friday. SPDR S&P Biotech ETF has a 1 year low of $81.14 and a 1 year high of $105.47. The company has a market cap of $5.67 billion, a PE ratio of 11.47 and a beta of 0.93. The stock’s 50-day moving average is $90.28 and its 200 day moving average is $95.02.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.